These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15371617)

  • 41. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normal variations and benign findings in pediatric 18F-FDG-PET/CT.
    Grant FD
    PET Clin; 2014 Apr; 9(2):195-208. PubMed ID: 25030282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
    Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
    World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
    Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
    Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 18F-FDG PET/CT in evaluating non-CNS pediatric malignancies.
    Tatsumi M; Miller JH; Wahl RL
    J Nucl Med; 2007 Dec; 48(12):1923-31. PubMed ID: 18056332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. False-positive FDG PET uptake--the role of PET/CT.
    Rosenbaum SJ; Lind T; Antoch G; Bockisch A
    Eur Radiol; 2006 May; 16(5):1054-65. PubMed ID: 16365730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
    Basu S; Houseni M; Alavi A
    Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect.
    Cohade C
    Semin Nucl Med; 2010 Jul; 40(4):283-93. PubMed ID: 20513450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical application of 18F-FDG PET/CT in the treatment of sarcomas].
    Borbély K; Németh Z; Kásler M
    Magy Onkol; 2014 Mar; 58(1):24-31. PubMed ID: 24712003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abdomen: normal variations and benign conditions resulting in uptake on FDG-PET/CT.
    Zukotynski K; Kim CK
    PET Clin; 2014 Apr; 9(2):169-83. PubMed ID: 25030280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron emission tomography/computed tomography fusion imaging in brown adipose tissue.
    Minotti AJ; Shah L; Keller K
    Clin Nucl Med; 2004 Jan; 29(1):5-11. PubMed ID: 14688591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The distinctive role of positron emission tomography/computed tomography in breast carcinoma with brown adipose tissue 2-fluoro-2-deoxy-d-glucose uptake.
    Heiba SI; Bernik S; Raphael B; Sandella N; Cholewinski W; Klein P
    Breast J; 2005; 11(6):457-61. PubMed ID: 16297092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PET/CT evaluation of the physiologic accumulation of 18F-FDG within the gallbladder vesicle.
    Murata Y; Watanabe H; Kubota K; Toda K; Nakamura S; Okouchi K; Shibuya H
    Nucl Med Biol; 2007 Nov; 34(8):961-6. PubMed ID: 17998099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls.
    Liu Y
    Ann Nucl Med; 2009 Feb; 23(2):107-12. PubMed ID: 19225932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].
    Bestic JM; Peterson JJ; Bancroft LW
    Radiographics; 2009; 29(5):1487-500. PubMed ID: 19755607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Searching for alternatives to full kinetic analysis in 18F-FDG PET: an extension of the simplified kinetic analysis method.
    Hapdey S; Buvat I; Carson JM; Carrasquillo JA; Whatley M; Bacharach SL
    J Nucl Med; 2011 Apr; 52(4):634-41. PubMed ID: 21421718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Basic concepts on 18F-FDG PET/CT: definitions and normal variants].
    Roldán-Valadez E; Vega-González I; Valdivieso-Cárdenas G; Rumoroso-García A; Morales-Santillán O; Osorio-Cardiel L
    Gac Med Mex; 2008; 144(2):137-46. PubMed ID: 18590033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT.
    Maurer AH; Burshteyn M; Adler LP; Steiner RM
    Radiographics; 2011; 31(5):1287-305. PubMed ID: 21918045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.